Male sex accelerates cognitive decline in GBA1 Parkinson's disease

被引:0
|
作者
Caminiti, Silvia Paola [1 ]
Avenali, Micol [1 ,2 ]
Galli, Alice [3 ]
Malito, Rachele [2 ]
Cuconato, Giada [4 ]
Galandra, Caterina [2 ]
Calabrese, Rosaria [2 ]
Pilotto, Andrea [3 ,5 ]
Padovani, Alessandro [3 ,5 ]
Blandini, Fabio [1 ,6 ]
Perani, Daniela [7 ]
Tassorelli, Cristina [1 ,2 ]
Valente, Enza Maria [2 ,4 ]
机构
[1] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[2] IRCCS C Mondino Fdn, Pavia, Italy
[3] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy
[4] Univ Pavia, Dept Mol Med, Pavia, Italy
[5] ASST Spedali Civili Brescia, Dept Continu Care & Frailty, Neurol Unit, Brescia, Italy
[6] Osped Maggiore Policlin, Ca Granda Fdn, Milan, Italy
[7] IRCCS San Raffaele Sci Inst, Milan, Italy
关键词
SLEEP BEHAVIOR DISORDER; QUALITY-OF-LIFE; DEMENTIA; IMPAIRMENT; CRITERIA; BIOMARKERS; MUTATIONS; MODELS; RISK; AGE;
D O I
10.1038/s41531-025-00883-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We evaluated 128 GBA and 432 nonGBA Parkinson's disease (PD) subjects available from Parkinson's Progression Markers Initiative. Baseline clinical features and dopaminergic activity were assessed, together with clinical follow-up (6.87 +/- 3.2 years). Survival analyses assessed the independent and interactive effects of sex and GBA1 mutations on cognitive decline. At baseline, GBA-PD males showed severe motor impairment, sleep disorders and memory deficits. Despite milder motor deficit, compared to GBA-PD males, GBA-PD females showed greater dopaminergic denervation, suggesting the effect of neural reserve. In longitudinal assessment, GBA-PD males showed greater MoCA rate of change per year and greater risk of cognitive impairment than GBA-PD females and nonGBA-PD. In GBA-PD males, both late age at onset and "severe/mild" GBA variants were associated with increased risk of cognitive impairment. Male sex and GBA1 carrier status have an additive value in increasing the risk of cognitive decline in PD. The effect of sex on GBA1-related pathology warrants further examination to address future trials design and patients' selection.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] The Functional Consequences of the 'African GBA1 Allele' of rs3115534 in Parkinson's disease (PD)
    Radefeldt, M.
    Demuth, L.
    Al-Ali, R.
    Fischer, S.
    Beetz, C.
    Bauer, P.
    MOVEMENT DISORDERS, 2024, 39 : S750 - S750
  • [42] Post Deep Brain Stimulation cognitive decline in GBA-related Parkinson's disease
    Weill, C.
    Gallant, A.
    Linetsky, E.
    Israel, Z.
    Arkadir, D.
    MOVEMENT DISORDERS, 2022, 37 : S578 - S578
  • [43] First clinicogenetic description of Parkinson's disease related to S107L GBA1 mutation
    Hertz, E.
    Thornqvist, M.
    Holmberg, B.
    Machaczka, M.
    Sidransky, E.
    Svenningsson, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 192 - 192
  • [44] A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
    den Heijer, Jonas M.
    Cullen, Valerie C.
    Quadri, Marialuisa
    Schmitz, Arnoud
    Hilt, Dana C.
    Lansbury, Peter
    Berendse, Henk W.
    van de Berg, Wilma D. J.
    de Bie, Rob M. A.
    Boertien, Jeffrey M.
    Boon, Agnita J. W.
    Contarino, M. Fiorella
    van Hilten, Jacobus J.
    Hoff, Jorrit, I
    van Mierlo, Tom
    Munts, Alex G.
    van der Plas, Anne A.
    Ponsen, Mirthe M.
    Baas, Frank
    Majoor-Krakauer, Danielle
    Bonifati, Vincenzo
    van Laar, Teus
    Groeneveld, Geert J.
    MOVEMENT DISORDERS, 2020, 35 (09) : 1667 - 1674
  • [45] VALIDATION OF STRATEGIES FOR MEASURING BLOOD GLUCOCEREBROSIDASE ENZYME ACTIVITY IN PARKINSON'S DISEASE WITH GBA1 VARIANT
    Park, K. -S.
    Hwangbo, J.
    Lee, J. -H.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [46] Lewy pathology formation in patient-derived GBA1 Parkinson's disease midbrain organoids
    Frattini, Emanuele
    Faustini, Gaia
    Lopez, Gianluca
    Carsana, Emma Veronica
    Tosi, Mattia
    Trezzi, Ilaria
    Magni, Manuela
    Solda, Giulia
    Straniero, Letizia
    Facchi, Daniele
    Samarani, Maura
    Marta-Ariza, Mitchell
    De Luca, Chiara Maria Giulia
    Vezzoli, Elena
    Pittaro, Alessandra
    Stepanyan, Astghik
    Silipigni, Rosamaria
    Rosety, Isabel
    Schwamborn, Jens C.
    Sardi, Sergio Pablo
    Moda, Fabio
    Corti, Stefania
    Comi, Giacomo P.
    Blandini, Fabio
    Tritsch, Nicolas X.
    Bortolozzi, Mario
    Ferrero, Stefano
    Cribiu, Fulvia Milena
    Wisniewski, Thomas
    Asselta, Rosanna
    Aureli, Massimo
    Bellucci, Arianna
    Di Fonzo, Alessio
    BRAIN, 2025,
  • [47] Longitudinal evaluation of olfactory function in individuals with Gaucher disease and GBA1 mutation carriers with and without Parkinson's disease
    Lopez, Grisel J.
    Lichtenberg, Jens
    Tayebi, Nahid
    Ryan, Emory
    Lecker, Abigail L.
    Sidransky, Ellen
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [48] Motor scores and sleep survey in GBA1 mutation carriers at risk for Parkinson Disease
    Rios, Andrea Otero
    Steward, Alta
    Patel, Nishka
    Lindstrom, Taylor
    Seid, Raya
    Tayebi, Nahid
    Sidransky, Ellen
    Lopez, Grisel
    NEUROLOGY, 2020, 94 (15)
  • [49] Exposure factors and clinical characteristics associated with Parkinson's disease in GBA1 variant carriers: A Chinese GBA1-PD intrafamilial survey
    Zhang, Xuxiang
    Zhao, Yuwen
    Jiang, Li
    Hu, Yuxuan
    Liu, Zhenhua
    Xu, Qian
    Wang, Chunyu
    Lei, Lifang
    Li, Peishan
    Tan, Zhihui
    Wu, Heng
    Shen, Lu
    Jiang, Hong
    Yan, Xinxiang
    Tang, Beisha
    Guo, Jifeng
    PARKINSONISM & RELATED DISORDERS, 2025, 130
  • [50] A newly implemented NGS-based method to detect GBA1 variants in patients with Parkinson's disease
    Monfrini, E.
    Palmieri, I.
    Cuconato, G.
    Percetti, M.
    Cortelli, P.
    Di Fonzo, A.
    Valente, E. M.
    MOVEMENT DISORDERS, 2023, 38 : S484 - S484